We serve Chemical Name:3-(Pyrrolidin-3-yl)pyridine hydrochloride CAS:150281-46-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(Pyrrolidin-3-yl)pyridine hydrochloride
CAS.NO:150281-46-2
Synonyms:3-Pyrrolidinopyridine oxalate;3-(3-Pyrrolidinyl)pyridine dihydrochloride;Pyridine,3-(3-pyrrolidinyl)-,(+)-(9CI);3-pyridin-3-yl-pyrrolidine;3-(3-pyrrolidinyl)pyridine;3-pyrrolidin-3-yl-pyridine;3-Pyrrolidine-3-yl pyridine
Molecular Formula:C9H13ClN2
Molecular Weight:184.66600
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:24.92000
Exact Mass:184.07700
LogP:2.28930
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Pyrrolidinopyridine oxalate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Pyrrolidine-3-yl pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Pyrrolidinopyridine oxalate Use and application,3-pyridin-3-yl-pyrrolidine technical grade,usp/ep/jp grade.
Related News: The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. 3-(Pyrrolidin-3-yl)pyridine hydrochloride manufacturer The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. 3-(Pyrrolidin-3-yl)pyridine hydrochloride supplier This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy. 3-(Pyrrolidin-3-yl)pyridine hydrochloride vendor The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island. 3-(Pyrrolidin-3-yl)pyridine hydrochloride factory The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward.